世界のペリンドプリルエルブミンAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Perindopril Erbumine API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL0463 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はペリンドプリルエルブミンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ペリンドプリルエルブミンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥99％、純度<99％）、用途別市場規模（ペリンドプリルエルブミン錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ペリンドプリルエルブミンAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・ペリンドプリルエルブミンAPIの種類別市場規模：純度≥99％、純度<99％ ・ペリンドプリルエルブミンAPIの用途別市場規模：ペリンドプリルエルブミン錠、その他 ・北米のペリンドプリルエルブミンAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのペリンドプリルエルブミンAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのペリンドプリルエルブミンAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のペリンドプリルエルブミンAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのペリンドプリルエルブミンAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Piramal Enterprises Limited、Cipla、Lupin Ltd、Glenmark Pharmaceuticals、ARCH PHARMALABS LIMITED、Zhejiang Huahai Pharmaceutial. Co., Ltd.、Aarti Industries Ltd.、Qiushi Pharm、Menovo Pharm ・ペリンドプリルエルブミンAPIのバリューチェーン・販売チャネル分析 ・ペリンドプリルエルブミンAPIの世界市場動向

Perindopril Erbumine is the tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, inhibiting ACE and the conversion of angiotensin I to angiotensin II; consequently, angiotensin II-mediated vasoconstriction and angiotensin II-stimulated aldosterone secretion from the adrenal cortex are inhibited and diuresis and natriuresis ensue.

Market Analysis and Insights: Global Perindopril Erbumine API Market
The global Perindopril Erbumine API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Perindopril Erbumine API Scope and Segment
Perindopril Erbumine API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Perindopril Erbumine API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥99%
Purity<99% Segment by Application Perindopril Erbumine Tablets Others By Company Piramal Enterprises Limited Cipla Lupin Ltd Glenmark Pharmaceuticals ARCH PHARMALABS LIMITED Zhejiang Huahai Pharmaceutial. Co., Ltd. Aarti Industries Ltd. Qiushi Pharm Menovo Pharm Production by Region China India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Perindopril Erbumine API Product Introduction
1.2 Market by Type
1.2.1 Global Perindopril Erbumine API Market Size Growth Rate by Type
1.2.2 Purity≥99%
1.2.3 Purity<99% 1.3 Market by Application 1.3.1 Global Perindopril Erbumine API Market Size Growth Rate by Application 1.3.2 Perindopril Erbumine Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Perindopril Erbumine API Production 2.1 Global Perindopril Erbumine API Production Capacity (2016-2027) 2.2 Global Perindopril Erbumine API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Perindopril Erbumine API Production by Region 2.3.1 Global Perindopril Erbumine API Historic Production by Region (2016-2021) 2.3.2 Global Perindopril Erbumine API Forecasted Production by Region (2022-2027) 2.4 China 2.5 India 3 Global Perindopril Erbumine API Sales in Volume & Value Estimates and Forecasts 3.1 Global Perindopril Erbumine API Sales Estimates and Forecasts 2016-2027 3.2 Global Perindopril Erbumine API Revenue Estimates and Forecasts 2016-2027 3.3 Global Perindopril Erbumine API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Perindopril Erbumine API Regions by Sales 3.4.1 Global Top Perindopril Erbumine API Regions by Sales (2016-2021) 3.4.2 Global Top Perindopril Erbumine API Regions by Sales (2022-2027) 3.5 Global Top Perindopril Erbumine API Regions by Revenue 3.5.1 Global Top Perindopril Erbumine API Regions by Revenue (2016-2021) 3.5.2 Global Top Perindopril Erbumine API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Perindopril Erbumine API Production Capacity by Manufacturers 4.2 Global Perindopril Erbumine API Sales by Manufacturers 4.2.1 Global Top Perindopril Erbumine API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Perindopril Erbumine API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Perindopril Erbumine API Sales in 2020 4.3 Global Perindopril Erbumine API Revenue by Manufacturers 4.3.1 Global Top Perindopril Erbumine API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Perindopril Erbumine API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Perindopril Erbumine API Revenue in 2020 4.4 Global Perindopril Erbumine API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Perindopril Erbumine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Perindopril Erbumine API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Perindopril Erbumine API Sales by Type 5.1.1 Global Perindopril Erbumine API Historical Sales by Type (2016-2021) 5.1.2 Global Perindopril Erbumine API Forecasted Sales by Type (2022-2027) 5.1.3 Global Perindopril Erbumine API Sales Market Share by Type (2016-2027) 5.2 Global Perindopril Erbumine API Revenue by Type 5.2.1 Global Perindopril Erbumine API Historical Revenue by Type (2016-2021) 5.2.2 Global Perindopril Erbumine API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Perindopril Erbumine API Revenue Market Share by Type (2016-2027) 5.3 Global Perindopril Erbumine API Price by Type 5.3.1 Global Perindopril Erbumine API Price by Type (2016-2021) 5.3.2 Global Perindopril Erbumine API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Perindopril Erbumine API Sales by Application 6.1.1 Global Perindopril Erbumine API Historical Sales by Application (2016-2021) 6.1.2 Global Perindopril Erbumine API Forecasted Sales by Application (2022-2027) 6.1.3 Global Perindopril Erbumine API Sales Market Share by Application (2016-2027) 6.2 Global Perindopril Erbumine API Revenue by Application 6.2.1 Global Perindopril Erbumine API Historical Revenue by Application (2016-2021) 6.2.2 Global Perindopril Erbumine API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Perindopril Erbumine API Revenue Market Share by Application (2016-2027) 6.3 Global Perindopril Erbumine API Price by Application 6.3.1 Global Perindopril Erbumine API Price by Application (2016-2021) 6.3.2 Global Perindopril Erbumine API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Perindopril Erbumine API Market Size by Type 7.1.1 North America Perindopril Erbumine API Sales by Type (2016-2027) 7.1.2 North America Perindopril Erbumine API Revenue by Type (2016-2027) 7.2 North America Perindopril Erbumine API Market Size by Application 7.2.1 North America Perindopril Erbumine API Sales by Application (2016-2027) 7.2.2 North America Perindopril Erbumine API Revenue by Application (2016-2027) 7.3 North America Perindopril Erbumine API Sales by Country 7.3.1 North America Perindopril Erbumine API Sales by Country (2016-2027) 7.3.2 North America Perindopril Erbumine API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Perindopril Erbumine API Market Size by Type 8.1.1 Europe Perindopril Erbumine API Sales by Type (2016-2027) 8.1.2 Europe Perindopril Erbumine API Revenue by Type (2016-2027) 8.2 Europe Perindopril Erbumine API Market Size by Application 8.2.1 Europe Perindopril Erbumine API Sales by Application (2016-2027) 8.2.2 Europe Perindopril Erbumine API Revenue by Application (2016-2027) 8.3 Europe Perindopril Erbumine API Sales by Country 8.3.1 Europe Perindopril Erbumine API Sales by Country (2016-2027) 8.3.2 Europe Perindopril Erbumine API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Perindopril Erbumine API Market Size by Type 9.1.1 Asia Pacific Perindopril Erbumine API Sales by Type (2016-2027) 9.1.2 Asia Pacific Perindopril Erbumine API Revenue by Type (2016-2027) 9.2 Asia Pacific Perindopril Erbumine API Market Size by Application 9.2.1 Asia Pacific Perindopril Erbumine API Sales by Application (2016-2027) 9.2.2 Asia Pacific Perindopril Erbumine API Revenue by Application (2016-2027) 9.3 Asia Pacific Perindopril Erbumine API Sales by Region 9.3.1 Asia Pacific Perindopril Erbumine API Sales by Region (2016-2027) 9.3.2 Asia Pacific Perindopril Erbumine API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Perindopril Erbumine API Market Size by Type 10.1.1 Latin America Perindopril Erbumine API Sales by Type (2016-2027) 10.1.2 Latin America Perindopril Erbumine API Revenue by Type (2016-2027) 10.2 Latin America Perindopril Erbumine API Market Size by Application 10.2.1 Latin America Perindopril Erbumine API Sales by Application (2016-2027) 10.2.2 Latin America Perindopril Erbumine API Revenue by Application (2016-2027) 10.3 Latin America Perindopril Erbumine API Sales by Country 10.3.1 Latin America Perindopril Erbumine API Sales by Country (2016-2027) 10.3.2 Latin America Perindopril Erbumine API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Perindopril Erbumine API Market Size by Type 11.1.1 Middle East and Africa Perindopril Erbumine API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Perindopril Erbumine API Revenue by Type (2016-2027) 11.2 Middle East and Africa Perindopril Erbumine API Market Size by Application 11.2.1 Middle East and Africa Perindopril Erbumine API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Perindopril Erbumine API Revenue by Application (2016-2027) 11.3 Middle East and Africa Perindopril Erbumine API Sales by Country 11.3.1 Middle East and Africa Perindopril Erbumine API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Perindopril Erbumine API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Corporation Information 12.1.2 Piramal Enterprises Limited Overview 12.1.3 Piramal Enterprises Limited Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Piramal Enterprises Limited Perindopril Erbumine API Product Description 12.1.5 Piramal Enterprises Limited Recent Developments 12.2 Cipla 12.2.1 Cipla Corporation Information 12.2.2 Cipla Overview 12.2.3 Cipla Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Cipla Perindopril Erbumine API Product Description 12.2.5 Cipla Recent Developments 12.3 Lupin Ltd 12.3.1 Lupin Ltd Corporation Information 12.3.2 Lupin Ltd Overview 12.3.3 Lupin Ltd Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Lupin Ltd Perindopril Erbumine API Product Description 12.3.5 Lupin Ltd Recent Developments 12.4 Glenmark Pharmaceuticals 12.4.1 Glenmark Pharmaceuticals Corporation Information 12.4.2 Glenmark Pharmaceuticals Overview 12.4.3 Glenmark Pharmaceuticals Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Glenmark Pharmaceuticals Perindopril Erbumine API Product Description 12.4.5 Glenmark Pharmaceuticals Recent Developments 12.5 ARCH PHARMALABS LIMITED 12.5.1 ARCH PHARMALABS LIMITED Corporation Information 12.5.2 ARCH PHARMALABS LIMITED Overview 12.5.3 ARCH PHARMALABS LIMITED Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 ARCH PHARMALABS LIMITED Perindopril Erbumine API Product Description 12.5.5 ARCH PHARMALABS LIMITED Recent Developments 12.6 Zhejiang Huahai Pharmaceutial. Co., Ltd. 12.6.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporation Information 12.6.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Overview 12.6.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Product Description 12.6.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments 12.7 Aarti Industries Ltd. 12.7.1 Aarti Industries Ltd. Corporation Information 12.7.2 Aarti Industries Ltd. Overview 12.7.3 Aarti Industries Ltd. Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Aarti Industries Ltd. Perindopril Erbumine API Product Description 12.7.5 Aarti Industries Ltd. Recent Developments 12.8 Qiushi Pharm 12.8.1 Qiushi Pharm Corporation Information 12.8.2 Qiushi Pharm Overview 12.8.3 Qiushi Pharm Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Qiushi Pharm Perindopril Erbumine API Product Description 12.8.5 Qiushi Pharm Recent Developments 12.9 Menovo Pharm 12.9.1 Menovo Pharm Corporation Information 12.9.2 Menovo Pharm Overview 12.9.3 Menovo Pharm Perindopril Erbumine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Menovo Pharm Perindopril Erbumine API Product Description 12.9.5 Menovo Pharm Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Perindopril Erbumine API Industry Chain Analysis 13.2 Perindopril Erbumine API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Perindopril Erbumine API Production Mode & Process 13.4 Perindopril Erbumine API Sales and Marketing 13.4.1 Perindopril Erbumine API Sales Channels 13.4.2 Perindopril Erbumine API Distributors 13.5 Perindopril Erbumine API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Perindopril Erbumine API Industry Trends 14.2 Perindopril Erbumine API Market Drivers 14.3 Perindopril Erbumine API Market Challenges 14.4 Perindopril Erbumine API Market Restraints 15 Key Finding in The Global Perindopril Erbumine API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Perindopril Erbumine API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥99%
Table 3. Major Manufacturers of Purity<99%
Table 4. Global Perindopril Erbumine API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Perindopril Erbumine API Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 6. Global Perindopril Erbumine API Production by Region (2016-2021) & (Kiloton)
Table 7. Global Perindopril Erbumine API Production Market Share by Region (2016-2021)
Table 8. Global Perindopril Erbumine API Production by Region (2022-2027) & (Kiloton)
Table 9. Global Perindopril Erbumine API Production Market Share by Region (2022-2027)
Table 10. Global Perindopril Erbumine API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Perindopril Erbumine API Sales by Region (2016-2021) & (Kiloton)
Table 12. Global Perindopril Erbumine API Sales Market Share by Region (2016-2021)
Table 13. Global Perindopril Erbumine API Sales by Region (2022-2027) & (Kiloton)
Table 14. Global Perindopril Erbumine API Sales Market Share by Region (2022-2027)
Table 15. Global Perindopril Erbumine API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Perindopril Erbumine API Revenue Market Share by Region (2016-2021)
Table 17. Global Perindopril Erbumine API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Perindopril Erbumine API Revenue Market Share by Region (2022-2027)
Table 19. Global Perindopril Erbumine API Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 20. Global Perindopril Erbumine API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Perindopril Erbumine API Production by Manufacturers (2016-2021) & (Kiloton)
Table 22. Global Perindopril Erbumine API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Perindopril Erbumine API Sales by Manufacturers (2016-2021) & (Kiloton)
Table 24. Global Perindopril Erbumine API Sales Share by Manufacturers (2016-2021)
Table 25. Global Perindopril Erbumine API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Perindopril Erbumine API Revenue Share by Manufacturers (2016-2021)
Table 27. Perindopril Erbumine API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Perindopril Erbumine API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Perindopril Erbumine API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perindopril Erbumine API as of 2020)
Table 30. Perindopril Erbumine API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Perindopril Erbumine API Product Offered
Table 32. Date of Manufacturers Enter into Perindopril Erbumine API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 35. Global Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 36. Global Perindopril Erbumine API Sales Share by Type (2016-2021)
Table 37. Global Perindopril Erbumine API Sales Share by Type (2022-2027)
Table 38. Global Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Perindopril Erbumine API Revenue Share by Type (2016-2021)
Table 41. Global Perindopril Erbumine API Revenue Share by Type (2022-2027)
Table 42. Perindopril Erbumine API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Perindopril Erbumine API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 45. Global Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 46. Global Perindopril Erbumine API Sales Share by Application (2016-2021)
Table 47. Global Perindopril Erbumine API Sales Share by Application (2022-2027)
Table 48. Global Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Perindopril Erbumine API Revenue Share by Application (2016-2021)
Table 51. Global Perindopril Erbumine API Revenue Share by Application (2022-2027)
Table 52. Perindopril Erbumine API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Perindopril Erbumine API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 55. North America Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 56. North America Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 59. North America Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 60. North America Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Perindopril Erbumine API Sales by Country (2016-2021) & (Kiloton)
Table 63. North America Perindopril Erbumine API Sales by Country (2022-2027) & (Kiloton)
Table 64. North America Perindopril Erbumine API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Perindopril Erbumine API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 67. Europe Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 68. Europe Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 71. Europe Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 72. Europe Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Perindopril Erbumine API Sales by Country (2016-2021) & (Kiloton)
Table 75. Europe Perindopril Erbumine API Sales by Country (2022-2027) & (Kiloton)
Table 76. Europe Perindopril Erbumine API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Perindopril Erbumine API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 79. Asia Pacific Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 80. Asia Pacific Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 83. Asia Pacific Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 84. Asia Pacific Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Perindopril Erbumine API Sales by Region (2016-2021) & (Kiloton)
Table 87. Asia Pacific Perindopril Erbumine API Sales by Region (2022-2027) & (Kiloton)
Table 88. Asia Pacific Perindopril Erbumine API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Perindopril Erbumine API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 91. Latin America Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 92. Latin America Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 95. Latin America Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 96. Latin America Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Perindopril Erbumine API Sales by Country (2016-2021) & (Kiloton)
Table 99. Latin America Perindopril Erbumine API Sales by Country (2022-2027) & (Kiloton)
Table 100. Latin America Perindopril Erbumine API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Perindopril Erbumine API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Perindopril Erbumine API Sales by Type (2016-2021) & (Kiloton)
Table 103. Middle East and Africa Perindopril Erbumine API Sales by Type (2022-2027) & (Kiloton)
Table 104. Middle East and Africa Perindopril Erbumine API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Perindopril Erbumine API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Perindopril Erbumine API Sales by Application (2016-2021) & (Kiloton)
Table 107. Middle East and Africa Perindopril Erbumine API Sales by Application (2022-2027) & (Kiloton)
Table 108. Middle East and Africa Perindopril Erbumine API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Perindopril Erbumine API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Perindopril Erbumine API Sales by Country (2016-2021) & (Kiloton)
Table 111. Middle East and Africa Perindopril Erbumine API Sales by Country (2022-2027) & (Kiloton)
Table 112. Middle East and Africa Perindopril Erbumine API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Perindopril Erbumine API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Piramal Enterprises Limited Corporation Information
Table 115. Piramal Enterprises Limited Description and Major Businesses
Table 116. Piramal Enterprises Limited Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Piramal Enterprises Limited Perindopril Erbumine API Product
Table 118. Piramal Enterprises Limited Recent Development
Table 119. Cipla Corporation Information
Table 120. Cipla Description and Major Businesses
Table 121. Cipla Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Cipla Perindopril Erbumine API Product
Table 123. Cipla Recent Development
Table 124. Lupin Ltd Corporation Information
Table 125. Lupin Ltd Description and Major Businesses
Table 126. Lupin Ltd Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Lupin Ltd Perindopril Erbumine API Product
Table 128. Lupin Ltd Recent Development
Table 129. Glenmark Pharmaceuticals Corporation Information
Table 130. Glenmark Pharmaceuticals Description and Major Businesses
Table 131. Glenmark Pharmaceuticals Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Glenmark Pharmaceuticals Perindopril Erbumine API Product
Table 133. Glenmark Pharmaceuticals Recent Development
Table 134. ARCH PHARMALABS LIMITED Corporation Information
Table 135. ARCH PHARMALABS LIMITED Description and Major Businesses
Table 136. ARCH PHARMALABS LIMITED Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. ARCH PHARMALABS LIMITED Perindopril Erbumine API Product
Table 138. ARCH PHARMALABS LIMITED Recent Development
Table 139. Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporation Information
Table 140. Zhejiang Huahai Pharmaceutial. Co., Ltd. Description and Major Businesses
Table 141. Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Zhejiang Huahai Pharmaceutial. Co., Ltd. Perindopril Erbumine API Product
Table 143. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Development
Table 144. Aarti Industries Ltd. Corporation Information
Table 145. Aarti Industries Ltd. Description and Major Businesses
Table 146. Aarti Industries Ltd. Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Aarti Industries Ltd. Perindopril Erbumine API Product
Table 148. Aarti Industries Ltd. Recent Development
Table 149. Qiushi Pharm Corporation Information
Table 150. Qiushi Pharm Description and Major Businesses
Table 151. Qiushi Pharm Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Qiushi Pharm Perindopril Erbumine API Product
Table 153. Qiushi Pharm Recent Development
Table 154. Menovo Pharm Corporation Information
Table 155. Menovo Pharm Description and Major Businesses
Table 156. Menovo Pharm Perindopril Erbumine API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Menovo Pharm Perindopril Erbumine API Product
Table 158. Menovo Pharm Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Perindopril Erbumine API Distributors List
Table 162. Perindopril Erbumine API Customers List
Table 163. Perindopril Erbumine API Market Trends
Table 164. Perindopril Erbumine API Market Drivers
Table 165. Perindopril Erbumine API Market Challenges
Table 166. Perindopril Erbumine API Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Perindopril Erbumine API Product Picture
Figure 2. Global Perindopril Erbumine API Market Share by Type in 2020 & 2027
Figure 3. Purity≥99% Product Picture
Figure 4. Purity<99% Product Picture
Figure 5. Global Perindopril Erbumine API Market Share by Application in 2020 & 2027
Figure 6. Perindopril Erbumine Tablets
Figure 7. Others
Figure 8. Perindopril Erbumine API Report Years Considered
Figure 9. Global Perindopril Erbumine API Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 10. Global Perindopril Erbumine API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Perindopril Erbumine API Production Market Share by Region (2016-2021)
Figure 12. Global Perindopril Erbumine API Production Market Share by Region (2022-2027)
Figure 13. Perindopril Erbumine API Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 14. Perindopril Erbumine API Production Growth Rate in India (2016-2027) & (Kiloton)
Figure 15. Global Perindopril Erbumine API Sales 2016-2027 (Kiloton)
Figure 16. Global Perindopril Erbumine API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Perindopril Erbumine API Revenue 2016-2027 (US$ Million)
Figure 18. Global Perindopril Erbumine API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 19. Global Perindopril Erbumine API Sales Market Share by Region (2016-2021)
Figure 20. Global Perindopril Erbumine API Sales Market Share by Region (2022-2027)
Figure 21. North America Perindopril Erbumine API Sales YoY (2016-2027) & (Kiloton)
Figure 22. North America Perindopril Erbumine API Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Europe Perindopril Erbumine API Sales YoY (2016-2027) & (Kiloton)
Figure 24. Europe Perindopril Erbumine API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Asia-Pacific Perindopril Erbumine API Sales YoY (2016-2027) & (Kiloton)
Figure 26. Asia-Pacific Perindopril Erbumine API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Latin America Perindopril Erbumine API Sales YoY (2016-2027) & (Kiloton)
Figure 28. Latin America Perindopril Erbumine API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Middle East & Africa Perindopril Erbumine API Sales YoY (2016-2027) & (Kiloton)
Figure 30. Middle East & Africa Perindopril Erbumine API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Perindopril Erbumine API Sales in 2020
Figure 32. The Top 10 and Top 5 Players Market Share by Perindopril Erbumine API Revenue in 2020
Figure 33. Perindopril Erbumine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 34. Global Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 35. Global Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 36. Global Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 37. Global Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 38. North America Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 39. North America Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 40. North America Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 41. North America Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 42. North America Perindopril Erbumine API Sales Share by Country (2016-2027)
Figure 43. North America Perindopril Erbumine API Revenue Share by Country (2016-2027)
Figure 44. United States Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 45. Canada Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 46. Europe Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 47. Europe Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 48. Europe Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 49. Europe Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 50. Europe Perindopril Erbumine API Sales Share by Country (2016-2027)
Figure 51. Europe Perindopril Erbumine API Revenue Share by Country (2016-2027)
Figure 52. Germany Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 53. France Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 54. U.K. Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 55. Italy Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 56. Russia Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 57. Asia Pacific Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 58. Asia Pacific Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 59. Asia Pacific Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 60. Asia Pacific Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 61. Asia Pacific Perindopril Erbumine API Sales Share by Region (2016-2027)
Figure 62. Asia Pacific Perindopril Erbumine API Revenue Share by Region (2016-2027)
Figure 63. China Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 64. Japan Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 65. South Korea Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 66. India Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 67. Australia Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 68. China Taiwan Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 69. Indonesia Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 70. Thailand Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 71. Malaysia Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 72. Latin America Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 73. Latin America Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 74. Latin America Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 75. Latin America Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 76. Latin America Perindopril Erbumine API Sales Share by Country (2016-2027)
Figure 77. Latin America Perindopril Erbumine API Revenue Share by Country (2016-2027)
Figure 78. Mexico Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 79. Brazil Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 80. Argentina Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 81. Middle East and Africa Perindopril Erbumine API Sales Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Perindopril Erbumine API Revenue Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Perindopril Erbumine API Sales Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Perindopril Erbumine API Revenue Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Perindopril Erbumine API Sales Share by Country (2016-2027)
Figure 86. Middle East and Africa Perindopril Erbumine API Revenue Share by Country (2016-2027)
Figure 87. Turkey Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 88. Saudi Arabia Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 89. UAE Perindopril Erbumine API Revenue (2016-2027) & (US$ Million)
Figure 90. Perindopril Erbumine API Value Chain
Figure 91. Perindopril Erbumine API Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

---